Not all studies investigating S100B could confirm these findings: Kondrup et al. did not find any significant differences in S100B level between NSCLC patients with IMD and those without (0.049 μg/L vs. 0.044 μg/L, p = 0.852) [90]. Here, S100B is linked to non-small cell lung carcinoma.